Engine Capital LP, a shareholder of each of PFSweb Inc (PFSW) and Speed Commerce Inc (NASDAQ:SPDC), on Monday, 29 December 2014 said that a combination of the two companies would create strong growth opportunities. On Friday shares of Speed Commerce, Inc. (NASDAQ:SPDC) closed at $2.49. Company’s sales growth for last 5 years was -29.10% and EPS growth for next 5 years is recorded as 15.00%.
Intel Corporation (NASDAQ:INTC) posted its fiscal’14 results yesterday, beating both earnings and revenues estimates, but company shares are down 2.3% pre-market today, perhaps due to the company’s ballooning operating loss in its mobile and communications group segment. Even though Intel succeeded in shipping 46 million tablet chips during the year, it did so at a grave cost. Intel Corporation (NASDAQ:INTC) in last trading activity advanced 0.72% to close at $36.45. Company weekly performance is -0.84% while its quarterly performance stands at 18.92%. Intel Corporation (NASDAQ:INTC) is -3.83% away from its 52 week high.
NxStage Medical Inc. (NASDAQ:NXTM) President Joseph E. Turk, Jr. sold 1,500 shares of NxStage Medical stock on the open market in a transaction that occurred on Tuesday, January 13th. The shares were sold at an average price of $18.35, for a total transaction of $27,525.00. Following the completion of the transaction, the president now directly owns 115,075 shares of the company’s stock, valued at approximately $2,111,626.25. On last trading day Nxstage Medical, Inc. (NASDAQ:NXTM) advanced 1.42% to close at $18.59. Its volatility for the week is 3.09% while volatility for the month is 3.34%. NXTM’s sales growth for past 5 years was 15.40% and its EPS growth for past 5 years was 24.10%. Nxstage Medical, Inc. (NASDAQ:NXTM) monthly performance is 10.33%.
Insys Therapeutics, Inc. (NASDAQ: INSY) announced progress and expected milestones for multiple projects in its pipeline of innovative supportive care and therapy products and candidates. The Company intends to submit a New Drug Application (NDA) to the Food and Drug Administration (FDA) and to advance five programs into Phase III clinical trials in 2015. INSYS Therapeutics, Inc. (NASDAQ:INSY) has 0.70% insider ownership while its institutional ownership stands at 40.60%. In last trading activity company’s stock closed at $46.72.
Sify Technologies Limited (NASDAQ:SIFY), a player in Managed Enterprise, Network, IT and Software servicesin India with global delivery capabilities, has announced that it will report its unaudited IFRS financial results for the third quarterended December 31, 2014 on Tuesday, January 20, 2015 before the market opens. On last trading day Sify Technologies Limited (NASDAQ:SIFY) advanced 3.65% to close at $1.42. Its volatility for the week is 6.67% while volatility for the month is 4.84%. SIFY’s sales growth for past 5 years was 11.20% and its EPS growth for past 5 years was 16.20%. Sify Technologies Limited (NASDAQ:SIFY) monthly performance is 6.77%.